Shire Viropharma Stock Price, News & Analysis (NASDAQ:VPHM)

Previous CloseN/A
Today's RangeN/A
52-Week Range$23.13 - $50.01
Average VolumeN/A
Market Capitalization$3.30 billion
P/E RatioN/A
Dividend YieldN/A

About Shire Viropharma (NASDAQ:VPHM)

Shire Viropharma logoViroPharma Incorporated (ViroPharma) is biotechnology company. The Company is engaged in the development and commercialization of solutions for physician specialists to address unmet medical needs of patients living with diseases that have few if any clinical therapeutic options including therapeutics for rare and orphan diseases. Its product development portfolio is focused on four programs: inryze (C1 esterase inhibitor [human]) for management of hereditary angioedema, maribavir for cytomegalovirus (CMV) infection, VP 20621 for the management of C. difficile-associated diarrhea (CDAD) and VP20629, which the Company expects to develop for the treatment of Friedreich's Ataxia. Its product development portfolio is focused on: C1 esterase inhibitor [human], maribavir for cytomegalovirus (CMV) infection, VP20621 (prevention of recurrent CDAD) and VP20629 (treatment of Friedreich's Ataxia). On January 23, 2014, Shire Plc completed tender offer for 79.5% of ViroPharma Inc.

Receive VPHM News and Ratings via Email

Sign-up to receive the latest news and ratings for VPHM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding Shares65,860,000

Shire Viropharma (NASDAQ:VPHM) Frequently Asked Questions

What is Shire Viropharma's stock symbol?

Shire Viropharma trades on the NASDAQ under the ticker symbol "VPHM."

How were Shire Viropharma's earnings last quarter?

Shire Viropharma Inc (NASDAQ:VPHM) issued its earnings results on Thursday, October, 24th. The biotechnology company reported $0.20 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.05 by $0.15. The biotechnology company earned $113 million during the quarter, compared to analysts' expectations of $113.35 million. Shire Viropharma's quarterly revenue was up 24.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.10 EPS. View Shire Viropharma's Earnings History.

Who are some of Shire Viropharma's key competitors?

Has Shire Viropharma been receiving favorable news coverage?

News coverage about VPHM stock has been trending positive recently, Accern Sentiment reports. Accern rates the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Shire Viropharma earned a coverage optimism score of 0.39 on Accern's scale. They also assigned news stories about the biotechnology company an impact score of 45.19 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of Shire Viropharma?

Shares of VPHM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How big of a company is Shire Viropharma?

Shire Viropharma has a market capitalization of $3.30 billion.

How can I contact Shire Viropharma?

Shire Viropharma's mailing address is 730 Stockton Dr, EXTON, PA 19341-1171, United States. The biotechnology company can be reached via phone at +1-610-4587300.

MarketBeat Community Rating for Shire Viropharma (VPHM)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  185 (Vote Outperform)
Underperform Votes:  191 (Vote Underperform)
Total Votes:  376
MarketBeat's community ratings are surveys of what our community members think about Shire Viropharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Shire Viropharma (NASDAQ:VPHM) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Shire Viropharma (NASDAQ:VPHM) Earnings History and Estimates Chart

Earnings by Quarter for Shire Viropharma (NASDAQ:VPHM)

Shire Viropharma (NASDAQ VPHM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2013Q313$0.05$0.20$113.35 million$113.00 millionViewN/AView Earnings Details
8/1/2013Q2 2013$0.01$0.15$105.06 million$104.00 millionViewN/AView Earnings Details
5/1/2013Q1 2013$0.04$0.15$108.47 million$107.00 millionViewN/AView Earnings Details
2/27/2013Q4 2012$0.03$0.10$103.06 million$106.50 millionViewN/AView Earnings Details
10/25/2012$0.13$0.10ViewN/AView Earnings Details
8/9/2012$0.19$0.09ViewN/AView Earnings Details
5/1/2012$0.42$0.37ViewN/AView Earnings Details
2/28/2012$0.44$0.65ViewN/AView Earnings Details
10/27/2011$0.37$0.56ViewN/AView Earnings Details
7/28/2011$0.41$0.28ViewN/AView Earnings Details
4/28/2011$0.41$0.40ViewN/AView Earnings Details
2/24/2011$0.32$0.43ViewN/AView Earnings Details
10/27/2010Q3 2010$0.31$0.52ViewN/AView Earnings Details
7/28/2010Q2 2010$0.30$0.34ViewN/AView Earnings Details
4/28/2010Q1 2010$0.31$0.29ViewN/AView Earnings Details
2/24/2010Q4 2009$0.24$0.23ViewN/AView Earnings Details
10/28/2009Q3 2009$0.26$0.34ViewN/AView Earnings Details
7/29/2009Q2 2009$0.19$0.20ViewN/AView Earnings Details
4/29/2009Q1 2009$0.15$0.09ViewN/AView Earnings Details
2/24/2009Q4 2008$0.16$0.02ViewN/AView Earnings Details
10/29/2008Q3 2008$0.23$0.33ViewN/AView Earnings Details
7/30/2008Q2 2008$0.26$0.30ViewN/AView Earnings Details
4/30/2008Q1 2008$0.23$0.22ViewN/AView Earnings Details
2/27/2008Q4 2007$0.20$0.25ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Shire Viropharma (NASDAQ:VPHM) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Shire Viropharma (NASDAQ:VPHM)

No dividend announcements for this company have been tracked by

Insider Trades

Shire Viropharma (NASDAQ VPHM) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Shire Viropharma (NASDAQ:VPHM)

Shire Viropharma (NASDAQ VPHM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/24/2012Colin Md BroomVPSell17,500$22.53$394,275.00View SEC Filing  
12/3/2012John Peter Wolf IIIVPSell18,000$24.85$447,300.00View SEC Filing  
12/3/2012William D Md ClaypoolDirectorSell10,000$24.80$248,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Shire Viropharma (NASDAQ VPHM) News Headlines

Reviewing Senomyx (SNMX) and Shire Viropharma (VPHM)Reviewing Senomyx (SNMX) and Shire Viropharma (VPHM) - March 4 at 7:08 PM
Critical Review: Adamis Pharmaceuticals Corporation (ADMP) and Shire Viropharma (VPHM)Critical Review: Adamis Pharmaceuticals Corporation (ADMP) and Shire Viropharma (VPHM) - October 14 at 10:46 AM
Contrasting Shire Viropharma (VPHM) & BioLife Solutions (BLFS)Contrasting Shire Viropharma (VPHM) & BioLife Solutions (BLFS) - September 12 at 2:26 AM
Comparing Eli Lilly and (LLY) & Shire Viropharma (VPHM)Comparing Eli Lilly and (LLY) & Shire Viropharma (VPHM) - September 9 at 6:22 PM
Promising New Treatment Emerges For Deadly C. difficile ColitisPromising New Treatment Emerges For Deadly C. difficile Colitis - May 5 at 11:00 AM

SEC Filings

Shire Viropharma (NASDAQ:VPHM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Shire Viropharma (NASDAQ:VPHM) Income Statement, Balance Sheet and Cash Flow Statement


Shire Viropharma (NASDAQ VPHM) Stock Chart for Wednesday, March, 21, 2018

Loading chart…

This page was last updated on 3/21/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.